Don't Wait For New Covid Vaccine: Pharmacists

"); jQuery("#212 h3").html("

Related News Programmes

"); });

2021-12-05 HKT 15:59

Share this story

facebook

  • The president of the Society of Hospital Pharmacists of Hong Kong, William Chui (right), says the government should considering buying the Sinopharm vaccine. Photo: RTHK

    The president of the Society of Hospital Pharmacists of Hong Kong, William Chui (right), says the government should considering buying the Sinopharm vaccine. Photo: RTHK

Pharmacists on Sunday advised people not to wait for a second generation vaccine as the Omicron coronavirus variant continues to spread across the globe.

The call comes as about four out of 10 people polled by the Society of Hospital Pharmacists of Hong Kong said they still haven't been vaccinated.

About 5,600 people were quizzed by the group in October.

More than half of those who expressed an intention to eventually get inoculated said they are still waiting for a better vaccine to come, while others thought it wasn't urgent.

But the society's president, William Chui, urged people to reconsider their decision.

"It takes about at least about six months for the introduction of the vaccine against Omicron, the new variant. That's why I suggest people to have vaccination as soon as possible so that they have more neutralising anti-body in their system," he said.

Chui added that the survey showed the number of people who prefer the BioNTech jabs over Sinovac had increased significantly, as they become more concerned about the spread of variants.

About 86 percent of the respondents indicated that they prefer BioNTech, compared with just three percent who would opt or have opted for Sinovac.

"People know that the efficacy of the BioNTech vaccine is very high, about 91 percent in the real world data... Sinovac's efficacy is quite low, compared with BioNTech, talking about 55 to 60 percent," he said.

The society called on the government to consider procuring the Sinopharm vaccine – in addition to the current two – saying it has a relatively high efficacy rate.

RECENT NEWS

Alibaba Invests Over US$50 Billion To Drive AI And Cloud Expansion By 2028

Alibaba Group (9988.HK) revealed plans to invest over 380 billion yuan (US$52.44 billion) into its cloud computing and ... Read more

SFC IOSCO Asia-Pacific Meet-up Sets Roadmap For Sustainable And Secure Capital Markets

The Securities and Futures Commission (SFC) recently participated in a series of dialogues under the International Orga... Read more

WeLab Bank Accelerates AI Deployment With Deepseek To Enhance Efficiency

WeLab Bank has taken a significant step forward in its AI deployment strategy by exploring innovative solutions to enha... Read more

Fusion Bank Completes Core Banking System Migration In 10 Months With Tencent Cloud

Fusion Bank, a licensed digital bank in Hong Kong, has completed its migration to a new core banking system in collabor... Read more

Hong Kong Banks Can Begin Issuing Credit Cards In Mainland China From March 1

Hong Kong banks’ mainland credit cards will soon be available in mainland China, marking a significant step towards d... Read more

SFC Introduces ASPIRe Roadmap To Strengthen Virtual Asset Market In Hong Kong

The Securities and Futures Commission (SFC) outlined 12 key initiatives under the SFC virtual asset ASPIRe roadmap to e... Read more